
Other QC
In addition to dedicated solutions for autoimmune, microbiology, PCR, and flow cytometry testing, laboratories often require specialized quality controls for a broader range of diagnostic applications. These controls play a key role in ensuring accuracy, consistency, and reliability across diverse testing methodologies.
From biological therapies monitoring to body fluid analysis and hematology-related parameters, appropriate QC materials are essential to validate assay performance and maintain confidence in results.
Our portfolio of additional QC solutions includes a wide selection of controls for various techniques, including EIA, CLIA, POC, and other methodologies, helping laboratories maintain high-quality standards across multiple diagnostic areas.
Find the right QC solution for your extended diagnostic applications

Immuno-Trol -QC, solutions for biological therapies monitoring
- supports monitoring of patients treated with biologics and biosimilars, particularly in chronic inflammatory diseases (CID)
- containing stabilized human blood cells
- enables theranostic approaches, including monitoring of biologics used in oncology
- designed for immunoassay-based techniques to ensure reliable and consistent results

Body Fluid QC – Procedural controls for body fluid analysis
- controls for RBC and WBC counts, crystal identification and white blood cell differentiation
- supports routine and specialized body fluid testing with stable and reliable materials
A1c Cellular QC – Whole blood controls for HbA1c testing
- the only HbA1c control with intact red blood cells, closely mimicking patient samples
- validates the entire analytical process, ensuring accurate instrument and reagent performance
ESR QC – Controls for erythrocyte sedimentation rate testing
- whole blood controls for automated and manual ESR methods
- compatible with multiple techniques and instruments, ensuring consistent and reliable results.
Other QC
| wdt_ID | wdt_created_by | wdt_created_at | wdt_last_edited_by | wdt_last_edited_at | PRODUCT | CATEGORY | TECHNIQUE | MORE INFO |
|---|---|---|---|---|---|---|---|---|
| 437 | bmd | 27/08/2026 11:25 AM | bmd | 27/08/2026 11:25 AM | Cell-Chex L1-UC, L2 | Body Fluid Streck QC | various | |
| 438 | bmd | 27/08/2026 11:25 AM | bmd | 27/08/2026 11:25 AM | Cell-Chex L1-UC, L2 | Body Fluid Streck QC | various | |
| 439 | bmd | 27/08/2026 11:25 AM | bmd | 27/08/2026 11:25 AM | Cell-Chex L1-CC | Body Fluid Streck QC | various | |
| 440 | bmd | 27/08/2026 11:25 AM | bmd | 27/08/2026 11:25 AM | Cell-Chex L1-CC | Body Fluid Streck QC | various | |
| 441 | bmd | 27/08/2026 11:25 AM | bmd | 27/08/2026 11:25 AM | Cell-Chex L1-UC, L1-CC, L2 | Body Fluid Streck QC | various | |
| 442 | bmd | 27/08/2026 11:25 AM | bmd | 27/08/2026 11:25 AM | Cell-Chex L1-UC | Body Fluid Streck QC | various | |
| 443 | bmd | 27/08/2026 11:25 AM | bmd | 27/08/2026 11:25 AM | Cell-Chex L2 | Body Fluid Streck QC | various | |
| 444 | bmd | 27/08/2026 11:25 AM | bmd | 27/08/2026 11:25 AM | Sperm-Chex Post VC, 1*pos & 1*neg | Body Fluid Streck QC | various | |
| 445 | bmd | 27/08/2026 11:25 AM | bmd | 27/08/2026 11:25 AM | Sperm-Chex L1,2 | Body Fluid Streck QC | various | |
| 446 | bmd | 27/08/2026 11:25 AM | bmd | 27/08/2026 11:25 AM | ESR-Chex 2*9ml LV1&LV2 | ESR Streck QC | ||
| 447 | bmd | 27/08/2026 11:25 AM | bmd | 27/08/2026 11:25 AM | ESR-Chex 4*9ml LV1&LV2 | ESR Streck QC | ||
| 448 | bmd | 27/08/2026 11:25 AM | bmd | 27/08/2026 11:25 AM | ESR-Chex 8*9ml LV1&LV2 | ESR Streck QC | ||
| 449 | bmd | 27/08/2026 11:25 AM | bmd | 27/08/2026 11:25 AM | ESR-Chex 12*9ml LV1&LV2 | ESR Streck QC | ||
| 450 | bmd | 27/08/2026 11:25 AM | bmd | 27/08/2026 11:25 AM | ESR-Chex Plus LV1&LV2 | ESR Streck QC | ||
| 451 | bmd | 27/08/2026 11:25 AM | bmd | 27/08/2026 11:25 AM | ESR-Chex Plus LV1&LV3 | ESR Streck QC | ||
| 452 | bmd | 27/08/2026 11:25 AM | bmd | 27/08/2026 11:25 AM | ez-Tracker Adalimumab Control | ez-Tracker Calibrators & Controls | EIA, CLIA, POC | https://bmd.be/wp-content/uploads/2026/08/ez-Tracker-EN-11052026_BMD.pdf |
| 453 | bmd | 27/08/2026 11:25 AM | bmd | 27/08/2026 11:25 AM | ez-Tracker Anti-Adalimumab Control | ez-Tracker cal & QC | EIA, CLIA, POC | https://bmd.be/wp-content/uploads/2026/08/ez-Tracker-EN-11052026_BMD.pdf |
| 454 | bmd | 27/08/2026 11:25 AM | bmd | 27/08/2026 11:25 AM | ez-Tracker Infliximab Control | ez-Tracker cal & QC | EIA, CLIA, POC | https://bmd.be/wp-content/uploads/2026/08/ez-Tracker-EN-11052026_BMD.pdf |
| 455 | bmd | 27/08/2026 11:25 AM | bmd | 27/08/2026 11:25 AM | ez-Tracker Anti-Infliximab Control | ez-Tracker cal & QC | EIA, CLIA, POC | https://bmd.be/wp-content/uploads/2026/08/ez-Tracker-EN-11052026_BMD.pdf |
| 456 | bmd | 27/08/2026 11:25 AM | bmd | 27/08/2026 11:25 AM | ez-Tracker Anti-Infliximab Total Ab Cont | ez-Tracker cal & QC | EIA, CLIA, POC | https://bmd.be/wp-content/uploads/2026/08/ez-Tracker-EN-11052026_BMD.pdf |
| 457 | bmd | 27/08/2026 11:25 AM | bmd | 27/08/2026 11:25 AM | ez-Tracker Etanercept Control | ez-Tracker cal & QC | EIA, CLIA, POC | https://bmd.be/wp-content/uploads/2026/08/ez-Tracker-EN-11052026_BMD.pdf |
| 458 | bmd | 27/08/2026 11:25 AM | bmd | 27/08/2026 11:25 AM | ez-Tracker Anti-Etanercept Control | ez-Tracker cal & QC | EIA, CLIA, POC | https://bmd.be/wp-content/uploads/2026/08/ez-Tracker-EN-11052026_BMD.pdf |
| 459 | bmd | 27/08/2026 11:25 AM | bmd | 27/08/2026 11:25 AM | ez-Tracker Golimumab Control | ez-Tracker cal & QC | EIA, CLIA, POC | https://bmd.be/wp-content/uploads/2026/08/ez-Tracker-EN-11052026_BMD.pdf |
| 460 | bmd | 27/08/2026 11:25 AM | bmd | 27/08/2026 11:25 AM | ez-Tracker Anti-Golimumab Control | ez-Tracker cal & QC | EIA, CLIA, POC | https://bmd.be/wp-content/uploads/2026/08/ez-Tracker-EN-11052026_BMD.pdf |
| 461 | bmd | 27/08/2026 11:25 AM | bmd | 27/08/2026 11:25 AM | ez-Tracker Vedolizumab Control | ez-Tracker cal & QC | EIA, CLIA, POC | https://bmd.be/wp-content/uploads/2026/08/ez-Tracker-EN-11052026_BMD.pdf |